Literature DB >> 23994763

Simultaneous determination of five phenolic components and paeoniflorin in rat plasma by liquid chromatography-tandem mass spectrometry and pharmacokinetic study after oral administration of Cerebralcare granule(®).

Xiang-yang Wang1, Xiao-hui Ma, Wei Li, Yang Chu, Jia-hua Guo, Shu-ming Li, Jun-mei Wang, Hong-chao Zhang, Shui-ping Zhou, Yong-hong Zhu.   

Abstract

A simple, sensitive and selective high-performance liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) method was developed for simultaneous determination and pharmacokinetic study of six active components, protocatechuic acid, chlorogenic acid, caffeic acid, ferulic acid rosmarinic acid and paeoniflorin in rat plasma after oral administration of Cerebralcare granule(®) for the first time. The method involves a simple liquid-liquid extraction with ethyl acetate. The separation was performed on a Luna C18 column (2.0×100mm i.d., 3.0μm, particle, Phenomenex, USA) with gradient elution using a mobile phase composed of acetonitrile and water (containing 0.1% formic acid) at a flow rate of 0.2ml/min. Electrospray ionization (ESI) in negative ion mode and selective reaction monitoring (SRM) was used for the quantification of six active components and internal standard (IS, Chloroamphenicol). The method was linear for all analytes over investigated range with all correlation coefficients greater than 0.9914. The lower limits of quantification (LLOQ) were 1.0ng/ml for protocatechuic acid, 1.0ng/ml for chlorogenic acid, 1.0ng/ml for caffeic acid, 5.0ng/ml for ferulic acid, 1.5ng/ml for rosmarinic acid and 6.0ng/ml for paeoniflorin, respectively. The intra- and inter-day precisions (R.S.D.%) were less than 6.60% and 11.68%, and accuracy (RE %) between -3.26% and 1.13% (n=6). The developed method was applied for the first time to the pharmacokinetic study of protocatechuic acid, chlorogenic acid, caffeic acid, ferulic acid, rosmarinic acid and paeoniflorin in rat plasma after oral administration of Cerebralcare granule(®).
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Active components; Cerebralcare granule(®); LC–MS/MS; Pharmacokinetics; Rat plasma

Mesh:

Substances:

Year:  2013        PMID: 23994763     DOI: 10.1016/j.jpba.2013.07.042

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Cerebralcare Granule(®), a Chinese Herb Compound Preparation, Attenuates D-Galactose Induced Memory Impairment in Mice.

Authors:  Zhuo Qu; Honggai Yang; Jingze Zhang; Liqin Huo; Hong Chen; Yuming Li; Changxiao Liu; Wenyuan Gao
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

2.  High-Throughput Determination of Sodium Danshensu in Beagle Dogs by the LCMS/MS Method, Employing Liquid-Liquid Extraction Based on 96-Well Format Plates.

Authors:  Jingjing Jiang; Xin Zhao; Xiuxiu Li; Shengyuan Wu; Shidan Yu; Yuefen Lou; Guorong Fan
Journal:  Molecules       Date:  2017-04-25       Impact factor: 4.411

3.  Neuroprotective effect of Cerebralcare Granule after cerebral ischemia/reperfusion injury.

Authors:  Xiao-Xiao Zhang; Fen-Fen He; Gui-Lin Yan; Ha-Ni Li; Dan Li; Yan-Ling Ma; Fang Wang; Nan Xu; Fei Cao
Journal:  Neural Regen Res       Date:  2016-04       Impact factor: 5.135

4.  Simultaneous Determination of Chlorogenic Acid Isomers and Metabolites in Rat Plasma Using LC-MS/MS and Its Application to A Pharmacokinetic Study Following Oral Administration of Stauntonia Hexaphylla Leaf Extract (YRA-1909) to Rats.

Authors:  Won-Gu Choi; Ju-Hyun Kim; Dong Kyun Kim; Yongnam Lee; Ji Seok Yoo; Dae Hee Shin; Hye Suk Lee
Journal:  Pharmaceutics       Date:  2018-09-02       Impact factor: 6.321

5.  UPLC-MS/MS Method for the Determination of 14 Compounds in Rat Plasma and Its Application in a Pharmacokinetic Study of Orally Administered Xiaoyao Powder.

Authors:  Mingyue Xu; Zhanling Xu; Qingxuan Xu; Hongyue Zhang; Mingyang Liu; Fang Geng; Ning Zhang
Journal:  Molecules       Date:  2018-09-30       Impact factor: 4.411

6.  Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions.

Authors:  Ou Qiao; Xinyu Zhang; Yi Zhang; Haixia Ji; Zhi Li; Xiaoying Han; Wenzhe Wang; Xia Li; Juan Wang; Changxiao Liu; Wenyuan Gao
Journal:  Chin Med       Date:  2021-06-28       Impact factor: 5.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.